Hear about what is happening in the pharmaceutical industry, including companies announcing business results, new products and mergers.

Industry News

Added 2 days ago Industry news

Tocagen and Forte Biosciences to merge.

Tocagen Inc. and Forte Biosciences, Inc., a privately held clinical-stage biopharmaceutical company developing a live biotherapeutic for the treatment of...

Added 4 days ago Industry news

Merck KGaA sells Allergopharma to Dermapharm

Merck KGaA, a leading science and technology company, signed an agreement to sell its allergy business Allergopharma to Dermapharm Holding...

Added 4 days ago Industry news

Aytu Bioscience acquires Innnovus Pharma

Aytu BioScience, Inc.a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs and Innovus Pharmaceuticals, Inc.,...

Added 13 days ago Industry news

Zealand Pharma A/S acquires Valeritas Holdings.

Zealand Pharma A/S, announces a bid to acquire substantially all assets from Valeritas Holdings, Inc. for a total cash consideration...

Added 18 days ago Industry news

Merck Inc.to spin-off products from its Women’s Health, trusted Legacy Brands, and Biosimilars businesses into a new, yet-to-be-named, independent, publicly traded company.

Merck announced its intention to spin-off products from its Women’s Health, trusted Legacy Brands, and Biosimilars businesses into a new,...

Added 19 days ago Industry news

Cerecor acquires Avei Genomic Medicine

Cerecor Inc. a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and...

Added 25 days ago Industry news

Conatus Pharma to merge with Histogen Inc and trade as Histogen Inc.

Conatus Pharmaceuticals Inc. and Histogen Inc., a privately-held regenerative medicine company with a novel biological platform that replaces and regenerates...

Added 27 days ago Industry news

Sorrento Therapeutics rejects takeover offer.

Sorrento Therapeutics, Inc. announced that, after reviewing the latest acquisition proposal in consultation with its advisors, Sorrento’s Board of Directors...

Added 1 month ago Industry news

BioNTech acquires Neon Therapeutics and NEO-PTC-01, a personalised neoantigen-targeted T cell therapy

BioNTech and Neon Therapeutics, Inc. announced that they have entered into a definitive merger agreement under which BioNTech will acquire...

Added 1 month ago Industry news

Eli Lilly to acquire Dermira and with it lebrikizumab, a treatment for atopic dermatitis

Eli Lilly and Company announced a definitive agreement for Lilly to acquire Dermira for $18.75 per share, or approximately $1.1...

Search all news articles